Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative ketamine for depressive symptoms in women with infertility or pregnancy loss
ChiCTR1800018434Phase 4Suspended
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in major depressive disorder (MDD) (2 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: BDI-II score. Started Sep 2018; status: suspended.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR1800018434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018434.